#ICYMI – In a recent @MedTechDaily column, Bill Doyle, our Executive Chairman, highlighted our history and innovative, #PatientForward approach to #CancerTreatment. While we’ve come a long way since the invention of #TTFields, we’re only at the beginning of our journey.
Mike Hugo hopes to dance with his daughters at their weddings someday. But if he isn’t there, his presence will still be felt, thanks to @TheTimMcGraw, who flew Mike to Nashville to record a duet of the song “My Little Girl.”
https://www.goodmorningamerica.com/family/story/dad-battling-cancer-duets-girl-tim-mcgraw-emotional-97747185
Today we announced the 5th Annual @AACR-Novocure Grants for Tumor Treating Fields Research Program, which includes research grants and career development awards totaling more than $1.5 million over the next three years. #TTFields https://www.novocure.com/novocure-announces-5th-annual-aacr-novocure-grants-for-tumor-treating-fields-research-program/
#ICYMI – @MedTechDaily recognized us as one of the #MedicalDevice industry’s top investors in research and development, citing how we dedicated 37.6% of our annual revenue to research-driven projects in 2022. Read the full article here: https://www.medicaldesignandoutsourcing.com/top-medtech-research-and-development-spenders-projects-big-100/
Linda Long always saw the road ahead as she pursued her dream, making history in the @PhillyFireDept as its first female fire battalion chief. Then she was diagnosed with glioblastoma (#GBM). https://www.novocure.com/stories/linda-long/
Today, we announced the reimbursement of Optune® together with temozolomide for the treatment of adult patients with newly diagnosed glioblastoma in France. https://www.novocure.com/novocure-announces-reimbursement-of-optune-for-the-treatment-of-newly-diagnosed-glioblastoma-in-france/ #GBM #glioblastoma #France
The final patient has been enrolled in the pivotal METIS study evaluating the efficacy of Tumor Treating Fields following stereotactic radiosurgery for treatment of patients with brain metastases resulting from non-small cell lung cancer. https://www.novocure.com/novocure-announces-last-patient-enrolled-in-pivotal-metis-study-of-tumor-treating-fields-in-brain-metastases-from-non-small-cell-lung-cancer/
We are now a member of the @ASTRO_org Corporate Advisory Council, represented by Pritesh Shah, our Chief Growth Officer. We are excited to share insights with and learn from this community. #radiationoncology #oncology https://www.astro.org/Affiliate/Industry/Categories-and-Benefits/Corporate-Advisory-Council
We are proud to announce that @drallysonocean has joined our Board of Directors. “I look forward to collaborating with Novocure so that we can enable Tumor Treating Fields therapy to reach as many patients as possible,” she said. @WeillCornell https://www.novocure.com/allyson-j-ocean-m-d-joins-novocure-board-of-directors/
Today, we reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a company update. https://www.novocure.com/novocure-reports-fourth-quarter-and-full-year-2022-financial-results-and-provides-company-update #earnings #NVCR